Clinical trial · Interventional
Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool
NCT04741503CI-TRIAL-00061092completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The investigators will collect feasibility data and assess the use of the decision support tool with end-users. The aim is to determine if women using the decision support tool make more informed choices measured by knowledge, attitudes, and intentions.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Screening | — | UNRESOLVED | — |
| Mammography | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
| Preventative Medicine | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breast Cancer Screening Decision Support Tool | Other | — | UNRESOLVED |
| National Cancer Institute Breast Cancer Screening PDQ | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Breast Cancer Screening Decision Support Tool
- description
- -After randomization, participants will complete pre-questionnaires, review the Breast Cancer Screening Decision support tool, and then complete the post-questionnaire.
- interventionNames
- Other: Breast Cancer Screening Decision Support Tool
- type
- ACTIVE_COMPARATOR
- label
- Standard Breast Cancer Screening Education
- description
- -After randomization, participants will complete pre-questionnaires, review the standard breast cancer screening education from the NCI, and then complete the post-questionnaire.
- interventionNames
- Other: National Cancer Institute Breast Cancer Screening PDQ
Primary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
- Maximum age
- 49 Years
Show eligibility criteria text
Inclusion Criteria: * Latina, Black, or non-Latina White women * Between the ages of 40-49 years * Can write, read, and understand English Exclusion Criteria: -Women with greater than an average self-reported risk of breast cancer will be ineligible for participation, as evidenced by any of the following: * Self-reported personal history of breast cancer (invasive, ductal carcinoma in situ \[DCIS\], or lobular carcinoma in situ\[LCIS\]) * Self-reported personal history of atypical hyperplasia * Self-reported first degree family member with history of breast cancer (e.g., mother, sister) * Self-reported known underlying genetic mutation such as a BRCA1/BRCA2 gene * Self-reported prior thoracic or chest wall radiation therapy
References
Publications (1)
- DERIVEDRiganti P, Ruiz Yanzi MV, Escobar Liquitay CM, Sgarbossa NJ, Alarcon-Ruiz CA, Kopitowski KS, Franco JV. Shared decision-making for supporting women's decisions about breast cancer screening. Cochrane Database Syst Rev. 2024 May 10;5(5):CD013822. doi: 10.1002/14651858.CD013822.pub2. PMID 38726892